Acorda Names CMO
Executive Summary
Acorda Therapeutics Inc., a company focused on neurological disorders, has appointed Burkhard Blank chief medical officer (CMO) – effective immediately. Blank was appointed as the company’s interim CMO in January 2016 and has previous experience of serving as CMO for various biopharmaceutical companies including Boehringer Ingelheim GMBH. Blank has also been a strategic advisor to several biotechnology companies.
You may also be interested in...
Pipeline Watch: Five Approvals And 23 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Executives On The Move: Changes At The Top At Viatris And Clinuvel Among This Week's Announcements
Recent moves in the industry include C-suite shuffle at Brainstorm Cell Therapeutics and new CFOs at Faron Pharmaceuticals and Foghorn Therapeutics, among others.
Pipeline Watch: Six Approvals And 15 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.